CY1116484T1 - Φαρμακευτικες συνθεσεις εντακαπονης συνμικρονισμενης με σακχαροαλκοολες - Google Patents

Φαρμακευτικες συνθεσεις εντακαπονης συνμικρονισμενης με σακχαροαλκοολες

Info

Publication number
CY1116484T1
CY1116484T1 CY20121100050T CY121100050T CY1116484T1 CY 1116484 T1 CY1116484 T1 CY 1116484T1 CY 20121100050 T CY20121100050 T CY 20121100050T CY 121100050 T CY121100050 T CY 121100050T CY 1116484 T1 CY1116484 T1 CY 1116484T1
Authority
CY
Cyprus
Prior art keywords
sugar alcohols
pharmaceutical compositions
syncrominated
entacapone
relates
Prior art date
Application number
CY20121100050T
Other languages
English (en)
Inventor
Ritesh Kapoor
Sanjay Mate
Munish Talwar
Girish Kumar Jain
Original Assignee
Wockhardt Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Limited filed Critical Wockhardt Limited
Publication of CY1116484T1 publication Critical patent/CY1116484T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Η παρούσα εφεύρεση αφορά φαρμακευτικές συνθέσεις που περιλαμβάνουν εντακαπόνη ή φαρμακευτικώς αποδεκτά άλατα αυτής μαζί με μια η περισσότερες σακχαροαλκοόλες, όπου η εντακαπόνη είναι συν-μικρονισμένη με μια ή περισσότερες σακχαροαλκοόλες. Η εφεύρεση επίσης αφορά σε μεθόδους κατασκευής τέτοιων συνθέσεων.
CY20121100050T 2008-02-06 2012-01-17 Φαρμακευτικες συνθεσεις εντακαπονης συνμικρονισμενης με σακχαροαλκοολες CY1116484T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN264MU2008 2008-02-06
EP09708991A EP2293791B1 (en) 2008-02-06 2009-02-06 Pharmaceutical compositions of entacapone co-micronized with sugar alcohols

Publications (1)

Publication Number Publication Date
CY1116484T1 true CY1116484T1 (el) 2017-03-15

Family

ID=40626966

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121100050T CY1116484T1 (el) 2008-02-06 2012-01-17 Φαρμακευτικες συνθεσεις εντακαπονης συνμικρονισμενης με σακχαροαλκοολες

Country Status (20)

Country Link
US (1) US8728517B2 (el)
EP (1) EP2293791B1 (el)
JP (1) JP5651478B2 (el)
KR (1) KR101532810B1 (el)
CN (1) CN101939002B (el)
AT (1) ATE534382T1 (el)
AU (1) AU2009211030B2 (el)
BR (1) BRPI0907727A2 (el)
CA (1) CA2714113C (el)
CY (1) CY1116484T1 (el)
DK (1) DK2293791T3 (el)
ES (1) ES2377597T3 (el)
HR (1) HRP20120106T1 (el)
MX (1) MX2010008707A (el)
NZ (1) NZ587169A (el)
PL (1) PL2293791T3 (el)
PT (1) PT2293791E (el)
RU (1) RU2010136934A (el)
SI (1) SI2293791T1 (el)
WO (1) WO2009098663A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010023828A1 (de) * 2010-06-15 2011-12-15 IIP - Institut für industrielle Pharmazie, Forschungs- und Entwicklungsgesellschaft mbH Pharmazeutisches Präparat, welches Entacapon, Levodopa und Carbidopa enthält
CN106880607A (zh) * 2015-12-15 2017-06-23 北大方正集团有限公司 一种含有瑞戈非尼的口腔崩解片及其制备方法
CN115715767B (zh) * 2022-11-02 2023-06-09 石家庄四药有限公司 一种恩他卡朋片剂的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2642486B2 (ja) * 1989-08-04 1997-08-20 田辺製薬株式会社 難溶性薬物の超微粒子化法
US6599530B2 (en) * 1998-09-14 2003-07-29 Orion Corporation Oral compacted composition comprising catechol derivatives
FI109453B (fi) * 1999-06-30 2002-08-15 Orion Yhtymae Oyj Farmaseuttinen koostumus
EA013161B1 (ru) 2005-06-08 2010-02-26 Орион Корпорейшн Дозированная форма для перорального применения
GB2429645A (en) * 2006-03-10 2007-03-07 Sekhsaria Chemicals Ltd Solid pharmaceutical composition comprising a COMT inhibitor, a starch and a wetting agent

Also Published As

Publication number Publication date
US8728517B2 (en) 2014-05-20
HRP20120106T1 (hr) 2012-02-29
NZ587169A (en) 2011-03-31
KR20100117096A (ko) 2010-11-02
US20110052681A1 (en) 2011-03-03
AU2009211030A1 (en) 2009-08-13
BRPI0907727A2 (pt) 2017-06-13
EP2293791B1 (en) 2011-11-23
EP2293791A1 (en) 2011-03-16
PL2293791T3 (pl) 2012-04-30
PT2293791E (pt) 2012-01-11
WO2009098663A1 (en) 2009-08-13
MX2010008707A (es) 2011-03-25
SI2293791T1 (sl) 2012-03-30
ATE534382T1 (de) 2011-12-15
CN101939002B (zh) 2012-12-26
DK2293791T3 (da) 2012-02-13
AU2009211030B2 (en) 2013-12-05
KR101532810B1 (ko) 2015-06-30
CA2714113A1 (en) 2009-08-13
JP5651478B2 (ja) 2015-01-14
RU2010136934A (ru) 2012-03-20
CN101939002A (zh) 2011-01-05
CA2714113C (en) 2015-11-24
JP2011526241A (ja) 2011-10-06
ES2377597T3 (es) 2012-03-29

Similar Documents

Publication Publication Date Title
CY1124924T1 (el) Φαρμακευτικη συνθεση καρβετοκινης
CY1118048T1 (el) Αντι-ιικες ενωσεις
CY1115043T1 (el) Φαρμακευτικο σκευασμα
PH12016500216B1 (en) Stable pharmaceutical composition and methods of using same
EA201100503A1 (ru) Глюкозидные производные и их применения
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
IN2012DN02441A (el)
BRPI0908052A2 (pt) Composições farmacêuticas de entacapone, levodopa e carbidopa com biodisponibilidade melhorada
GT201000023A (es) Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met.
HN2011001810A (es) Sintesis de espirikpiridinas radiomarcadas con 18f a partir de precursores de tosilato y composiciones farmaceuticas estables de estas.
CU24037B1 (es) Dicianopiridinas alquilamino-sustituidas y sus profármacos de éster de aminoácido
ATE554066T1 (de) Entzündungshemmende substituierte cyclobutendionverbindungen
EA201500650A1 (ru) Фенилацетат l-орнитина и способы его получения
BR112012011328A2 (pt) inibidores de akt
DK2120923T3 (da) Anvendelse af substituerede pyranonsyrederivater til behandling af det metaboliske syndrom
WO2011048563A3 (en) Orally disintegrating tablets of betahistine
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону
MX2014001368A (es) Soluciones anti-inflamatorias estables para inyección.
CY1111914T1 (el) Μεθοδος συνθεσης της ιβαβραδινης και των αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ
WO2009118589A3 (en) Orally disintegrating compositions of rhein or diacerein
EA201071183A1 (ru) Безводная кристаллическая форма малеата орвепитанта
UY32757A (es) Derivados de pirazoles, su preparacion y su aplicacion terapeutica
CY1116484T1 (el) Φαρμακευτικες συνθεσεις εντακαπονης συνμικρονισμενης με σακχαροαλκοολες
CY1112855T1 (el) Παραγωγα των πυρρολοπυριδινο-2-καρβοξαμιδιων, η παρασκευη τους και η θεραπευτικη εφαρμογη τους
UY35004A (es) Forma amorfa estabilizada de la agomelatina, su procedimiento de preparación y las composiciones farmacéuticas que la contienen